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1684-1182/Copyright ª 2015, TaiwanBackground/Purpose: Enterotoxigenic Bacteroides fragilis (ETBF) and toxin-encoding Clos-
tridium difficile (TXCD) are associated with gastroenteritis. Routine anaerobic blood culture
for recovery of these anaerobic pathogens is not used for the detection of their toxins, espe-
cially for toxin-variant TXCD. The aim of this study was to investigate the prevalence and risk
factors of the genotypes of these anaerobes in patients with acute diarrheal illnesses.
Methods: The data and samples of 513 patients with gastroenteritis were collected in a Tai-
pei emergency department from March 1, 2006 to December 31, 2009. Nonenterotoxigenic B.
fragilis (NTBF) and ETBF and the toxin genotypes of TXCD were detected by molecular
methods.
Results: The prevalence rates of NTBF, ETBF, and TXCD infections were 33.14%, 1.56%, and
2.34%, respectively. ETBF infections often occurred in the elderly (average age Z 67.13of Parasitology, National Cheng Kung University, Number 1, University Road, Tainan City 701, Taiwan,
ku.edu.tw (W.-C. Lin).
equally.
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10.1016/j.jmii.2014.12.005years) and during the cold, dry winters. TXCD infections were widely distributed in age and
often occurred in the warm, wet springs and summers. The symptoms of ETBF-infected pa-
tients were significantly more severe than those of NTBF-infected patients.
Conclusion: This study identified and analyzed the prevalence, risk factors, and clinical pre-
sentations of these anaerobic infections. Future epidemiologic and clinical studies are
needed to understand the role of ETBF and TXCD in human gastroenteritis.
Copyright ª 2015, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Acute gastroenteritis caused by infectious aerobic and/or
anaerobic etiological agents is often observed in the
emergency department (ED). The common symptoms
include vomiting, diarrhea, and dyspepsia. In Taiwan, vi-
ruses are the leading cause of gastroenteritis, followed by
bacteria, such as diarrheagenic Escherichia coli, Salmo-
nella spp. and Vibrio parahaemolyticus.1 The major
microfloral populations of the human gut are not only E.
coli and other fecal facultative microbes but also obligate
anaerobes.2 However, due to the time-consuming culture
technique and the difficulties of bacterial identification,
the routine testing of these pathogenic anaerobes is diffi-
cult, and approximately 70e80% are unculturable from
symptomatic patients.3 Many anaerobic bacterial infections
have reemerged as important clinical problems; among
these bacteria, enterotoxigenic Bacteroides fragilis (ETBF)
and toxin-encoding Clostridium difficile (TXCD) are the
most frequent and important anaerobic infectious agents of
diarrheal illness in humans.4e10
Although nonenterotoxigenic B. fragilis (NTBF) is a
common component of the colonic, ETBF strains can cause
gastrointestinal tract infections, acute inflammatory diar-
rhea, and other severe infections.4,6,11,12 ETBF secretes the
only known virulence factor, a 20-kDa zinc metalloprotease
toxindB. fragilis enterotoxin, also termed fragilysin.13,14
Because the diagnoses of the B. fragilis strains are tech-
nically difficult, no studies have reported the prevalence of
B. fragilis or the toxin-encoding rate in Taiwan.
C. difficile is one of the most common enteric anaerobic
pathogens. It was not considered a human pathogen until it
was implicated as the cause of antibiotic-associated pseu-
domembranous colitis.15,16 TXCD strains cause human in-
fections ranging from mild diarrhea to potentially life-
threatening pseudomembranous colitis through the pro-
duction of three toxins: toxins A and B and a less well-
known enzyme component, C. difficile binary toxin (CDT).
Recent studies suggest that toxins A and B are similar en-
terotoxins and that toxin B is even more potent than toxin A
in humans.17 Toxins A and B are encoded by two genes, tcdA
and tcdB,18 and have been reported in several countries
with varying prevalence rates.8,9,19e21 In addition to toxins
A and B, CDT has been found in one strain (CD196) of C.
difficile.22 Stubbs et al23 showed that CDT is an ADP-
ribosyltransferase consisting of the enzymatic component
and the binding component. Approximately 6% of the C.
difficile isolates isolated from patients in the USA andi D-D, et al., Prevalence and char
rgency department, Journal of MEurope, and from veterinary and environmental sources
contain the genes for CDT: cdtA (the enzyme) and cdtB (the
binding component).23 Because the virulence potential of
CDT is still unclear and commercial toxin detection kits for
C. difficile do not cover CDT, the prevalence of the geno-
types of the TXCD strains in Taiwan remains largely
unknown.
The specific aims of this study were to investigate the
prevalence and to identify the molecular characteristics of
NTBF, ETBF, and TXCD infections. We describe the clinical
presentations and potential risk factors of these acute
gastroenteritis cases in order to recall the medical
personnel to the importance of these neglected pathogens.
Methods
Patients
The study site was a Taipei ED. The data of 513 patients
were collected by a triage nurse from March 1, 2006 to
December 31, 2009. The primary case definitions were as
follows: (1) at least three loose stools or three instances of
vomiting; or (2) either diarrhea and/or vomiting plus two or
more additional symptoms, including abdominal pain,
fever, nausea, blood in the stool, or stool mucus.1 Patients
were excluded from the study if they were younger than 15
years, exhibited coughing, a sore throat, or runny nose, or
were bedridden. Patients aged >65 years were excluded
from the control group. Stool specimens were tested for
recognized enteropathogens, including viruses (norovirus,
rotavirus, and astrovirus), parasites (Giardia lamblia and
Entamoeba histolytica), and bacteria (suspected diarrhea-
genic E. coli, Salmonella spp., Shigella spp., Vibrio spp.,
Campylobacter spp., Aeromonas spp., and Staphylococcus
aureus with related enterotoxins).1
DNA extraction
A total of 0.5 g of each stool sample or 500 mL mixtures of
each rectal sample were mixed into 2.0 mL of 5.3M gua-
nidine thiocyanate. The mixture was heated at 95C while
shaking for 30 minutes and cooled to room temperature
prior to centrifuging for 5 minutes at 20,000  g. MagNA
Pure systems (Roche Diagnostics, Mannheim, Germany)
were used to isolate a total of 100 mL of DNA from 250 mL of
the supernatant according to the manufacturer’s in-
structions. Polymerase chain reaction (PCR) wasacterization of enterotoxigenic Bacteroides fragilis and toxigenic
icrobiology, Immunology and Infection (2015), http://dx.doi.org/
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The DNA was tested for the presence of the small subunit
rRNA gene.
gyrB-based real-time PCR for detecting B. fragilis
The B. fragilis gyrB-based real-time PCR system was per-
formed according to the protocol established by Lee and
Lee.24 A CFX96 real-time PCR System (Bio-Rad, Hercules,
CA, USA) was used with a total of 25 mL of mixture, which
consisted of 5 mL of template DNA, 12.5 mL of a KAPA Probe
Fast qPCR kit (KAPA Biosystems, Wilmington, MA, USA),
500nM of each gyrB-based primer (Bf904f/Bf958R), and
250nM of the gyrB-based TaqMan probe (Bf923MGB) labeled
with 6-carboxyfluorescein (FAM; Table 1).24,25,26 Water,
instead of template DNA, served as an additional negative
control for each PCR reaction. The reactions were incu-
bated in a 96-well plate at 95C for 10 minutes, followed by
40 cycles of denaturation at 95C for 15 seconds and
annealing and extension at 60C for 1 minute.
Detection of the B. fragilis toxin gene by PCR
The B. fragilis enterotoxin gene, bft, was detected by PCR
to yield a 1-kb DNA band as described with some modifi-
cations.7,25 In brief, 5 mL of template DNA, 10 mL of Econ-
oTaq Plus Green 2  master mix (Lucigen, Middleton, WI,
USA), 500nM of each bft-based primer (bft F/bft R; Table
1) were mixed and brought to a final volume of 20 mL.
Water, instead of template DNA, served as an additional
negative control for each PCR reaction. The reactions were
incubated at 94C for 5 minutes, followed by 40 cycles of
denaturation at 94C for 1 minute, annealing at 65C for 1
minute, extension at 72C for 1 minute and a final exten-
sion at 72C for 3 minutes. PCR products were verified by
1% agarose gel electrophoresis with ethidium bromide
staining.Table 1 Nucleotide sequences and targets of primers and pro
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toxin genes
Multiplex real-time PCR, which included two duplex re-
actions, was used to characterize the C. difficile toxin
genes.26 One reaction was used to detect tcdA (FAM-labeled
probe) and tcdB [hexachloro-6-carboxy-fluorescein (HEX)-
labeled probe], and the other was used for cdtA (FAM-
labeled probe) and cdtB (HEX-labeled probe; Table 1). A
CFX96 real-time PCR System (Bio-Rad) was used with a total
of 25 mL of mixture, which consisted of 5 mL of template
DNA, 12.5 mL of a KAPA probe fast qPCR kit (KAPA Bio-
systems), two sets of primers at 50nM each (tcdAF/tcdAR,
tcdBF/tcdBR, cdtAF/cdtAR, and cdtBF/cdtBR), and the two
respective probe sets at 100nM in duplex reactions. Water,
instead of template DNA, served as an additional negative
control for each PCR reaction. The reactions were incu-
bated at 95C for 10 minutes, followed by 40 cycles of
denaturation at 95C for 1 minute, annealing at 54C for 30
seconds, and extension at 72C for 1 minute.Results
A total of 513 acute diarrheal fecal samples were collected
from the hospital ED in Taipei and screened for B. fragilis
by the gyrB-based real-time PCR system (Table 1). The ETBF
strains were further identified from B. fragilis-positive
samples by the PCR detection of the virulence factor gene
bft. The expected 1-kb product was amplified in ETBF in-
fections.7,25 Overall, Table 2 shows that there were 178 B.
fragilis infections, and eight isolates carried the bft gene.
The total prevalence rates of B. fragilis and ETBFs were
34.70% and 1.56%, respectively. The rate of B. fragilis
enterotoxin gene (bft) detection in the BF infections was
4.49%.
The annual B. fragilis- and ETBF-positive rates were
39.44% and 2.11% in 2006, 30.77% and 2.31% in 2007,bes used for real-time polymerase chain reaction and poly-
Target Gene Refs
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Table 2 Prevalence of Bacteroides fragilis and toxigenic Clostridium difficile in fecal samples
Samples BFs BF positive rate (%) ETBFs ETBF rate (%) ETBFs/BFs (%) TXCDs TXCD rate (%)
2006 142 56 39.44 3 2.11 5.36 4 2.82
2007 130 40 30.77 3 2.31 7.50 3 2.31
2008 134 51 38.06 2 1.49 3.92 4 2.99
2009 107 31 28.97 0 0 0.00 1 0.93
Total 513 178 34.70 8 1.56 4.49 12 2.34
BF Z Bacteroides fragilis; ETBF Z enterotoxigenic BF; TXCD Z toxin-encoding Clostridium difficile.
Figure 1. The prevalence rate of enterotoxigenic Bacter-
oides fragilis, toxigenic Clostridium difficile (A) and non-
enterotoxigenic B. fragilis (B) in seasons during 2006e2009.
Gray bars, sample number in each seasons; (A) (-, prevalence
rate (%) of enterotoxigenic B. fragilis in each season; :,
prevalence rate (%) of toxigenic C. difficile in each season; (B)
A, prevalence rate (%) of nonenterotoxigenic B. fragilis in
each season.
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respectively. There were no significant variances in the
annual prevalence rates of B. fragilis and ETBF infections,
except for ETBFs in 2009 (no positive cases). Interestingly,
half of the ETBF infections occurred in winter months
(DecembereFebruary) during 2006e2009. Fig. 1A shows
that the prevalence rate of ETBF infections in winter
months (DecembereFebruary; 2.61%) was significantly
higher than in the springs (MarcheMay; 0.74%), summers
(JuneeAugust; 0.86%), and autumns (SeptembereNo-
vember; 1.83%) included in the study. However, the
prevalence rate of NTBF infections was 35.29% in the
winter months and did not significantly differ from other
seasons (Fig. 1B). These data show that the prevalence
rate of ETBF infections was significantly higher during the
cold, dry winter months than during others; this was not
true for NTBF infections.
Of the 513 patients from whom acute diarrheal fecal
samples were collected in the ED, 493 (96.1%) returned
completed and usable questionnaires. According to the
triage records, no differences were noted between partic-
ipants and nonparticipants in terms of age, gender, or the
distribution of diarrhea symptoms, but nonparticipants
exhibited more cases of vomiting and abdominal pain. We
used caseecase comparisons to study the risk factors
associated with the infections.27 Fig. 2 shows the distribu-
tion of the age of ETBF-infected participants. The
mean  standard deviation age of patients with NTBF and
ETBF infections was 42.86  18.66 years and 67.13 years
and 12.62 years, respectively. The analyses demonstrate
that ETBF infections are more common among elderly than
younger individuals (aged > 15 years).
We analyzed the symptoms reported by the participants
and linked to the other pathogens. The frequency of diar-
rhea within 24 hours was significantly different between
ETBF and NTBF infections (Table S1). The median diarrhea
frequency within 24 hours in ETBF infections (10.0) was also
significantly higher than for NTBF infections (6.0).
The multiplex real-time PCR assay for TXCD was used to
screen and characterize the toxin genotypes of TXCD iso-
lates from the 513 ED samples from 2006 to 2009 (Table 1).
The toxin genes were detected in twelve samples, and the
total prevalence rate was 2.34%. There were no significant
differences in the annual prevalence rate from 2006 to 2008
(Table 2). Similar to the low incidence of ETBF in the same
year, only one TXCD-positive case was identified in 107
samples during 2009. However, unlike ETBF infections,
which often occur in dry, cold winters in Taiwan, the
prevalence rate of TXCD infections peaked in wet, warm
springs (4.44%) and summers (2.59%; Fig. 1A).Please cite this article in press as: Ji D-D, et al., Prevalence and char
Clostridium difficile in a Taipei emergency department, Journal of M
10.1016/j.jmii.2014.12.005We also studied the risk factors associated with TXCD
infection and compared them to the other infections. Un-
like ETBF infections, the mean  standard deviation of
patients with TXCD (46.42  21.61 years) were similar toacterization of enterotoxigenic Bacteroides fragilis and toxigenic
icrobiology, Immunology and Infection (2015), http://dx.doi.org/
Figure 2. The distribution of the age (years) of enterotoxi-
genic Bacteroides fragilis (-) and toxigenic Clostridium
difficile (A) patients.
Table 4 Prevalence of Bacteroides fragilis and toxigenic
Clostridium difficile coinfected with Giardia in fecal
samples
Numbers Giardia coinfections (%)
ETBF 8 3 (37.50)
TXCD 12 4 (33.33)
NTBF 170 22 (12.94)
Total fecal samples 513 80 (15.59)
ETBF Z enterotoxigenic Bacteroides fragilis;
NTBFZ nonenterotoxigenic B. fragilis; TXCDZ toxin-encoding
Clostridium difficile.
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participants had a nearly random distribution (Fig. 2).
Twelve TXCDs were detected by multiplex real-time PCR
for the toxin-encoding genes of TXCD: tcdA, tcdB, and CDT
(cdtA, cdtB). These 12 TXCD-positive samples were cate-
gorized into three different TXCD toxin genotypes
(Table 3). Nine samples were tcdAtcdBþCDT in
2006e2008, two were tcdAþtcdBþCDT in 2006 and 2009,
and one was tcdAtcdBþCDTþ in 2006. There was no sig-
nificant correlation between the symptom severity and the
toxin genotypes of TXCD and the patients with
tcdAþtcdBþCDT TXCD infection did not show a more
serious symptom.
The specimens were also analyzed for viruses (norovirus,
rotavirus, and astrovirus), parasites (G. lamblia and E.
histolytica), and bacteria (suspected diarrheagenical E.
coli, Salmonella spp., Shigella spp., Vibrio spp., Campylo-
bacter spp., Aeromonas spp., and S. aureus with related
enterotoxins). Interestingly, there was no significant cor-
relation between ETBF, TXCD, and other pathogens with
the exception of G. lamblia. Table 4 shows that the rates of
G. lamblia coexistence with ETBF (37.50%) and TXCD
(33.33%) were significantly higher than coexistence with
NTBF (22%; Table S2) and also higher than the prevalence of
G. lamblia in all ED specimens (15.59%).
Discussion
This is the first ED-based epidemiological study of ETBF and
TXCD infections in Taiwan. We identified and characterized
NTBF and ETBF infections and the toxin genotypes of TXCD
isolates from acute gastroenteritis patient diarrhea stool
samples using PCR and real-time PCR. This studyTable 3 The toxin types of toxigenic Clostridium difficile
(TXCD) in fecal samples
Toxin genes % of TXCD-positive samples
tcd A tcd B CDT
 þ  75.00 (9/12)
þ þ  16.67 (2/12)
 þ þ 8.33 (1/12)
CDT Z Clostridium difficile toxin.
Please cite this article in press as: Ji D-D, et al., Prevalence and char
Clostridium difficile in a Taipei emergency department, Journal of M
10.1016/j.jmii.2014.12.005demonstrates the prevalence rates, epidemiological data,
and clinical presentations of NTBF, ETBF, and TXCD in ED
patients suffering from acute gastroenteritis.
From our observations, the annual prevalence rates of
NTBF, ETBF, and TXCD infections were stable during
2006e2008. However, in 2009, there were no ETBF in-
fections and only one TXCD infection in the collected
samples, which may have been the result of the 2009
influenza H1N1 pandemic. A laboratory-based hand hygiene
campaign in Egypt demonstrated a 30% reduction in
absenteeism caused by diarrhea during the H1N1
pandemic.28 Although the mechanism of this phenomenon
was not clear and may be complicated, hand hygiene may
be one of the most important intervention methods.
Interestingly, the seasonal rates of NTBF infections were
stable, but the rates of ETBF infections were significantly
higher in the winter months than other months during
2006e2009 (Fig. 1). The observed seasonal variance of
NTBF and ETBF infections differs from a previous study in
Dhaka, Bangladesh.7 In Bangladesh, the infection rates of
NTBF and ETBF during the hot, dry spring months (March-
eMay) were significantly higher than during other months,
suggesting that the variation was due to ambient humidity
in addition to the season. Humidity level may affect ETBF
pathogenicity. Both of the ETBF infection peaks occurred in
the dry season in Taiwan and Bangladesh.
The toxin types of the TXCD strains found in this study
are in agreement with the findings of the presence of the
tcdAtcdBþ strains in clinical material, which have been
reported with prevalence rates varying from 0.2% to
56%.19e21,29 Our results show that the prevalence rate of
tcdAtcdBþ C. difficile was 1.75% in Taiwan (9/513), which
is similar to its prevalence in the USA and also from recent
epidemiological data here in Taiwan.21,29,30 A previous
study suggested that tcdAtcdBþ C. difficile strains had
spread throughout Far East Asia prior to 2000.9 In Korea, the
mean prevalence of tcdAtcdBþ C. difficile strains was <7%
until 2002, but it began to increase in 2003. By contrast, the
mean prevalence of tcdAþtcdB C. difficile strains was
>93% until 2002 but decreased to 35.2% in 2004.9 In the
present study, we demonstrated that the tcdtcdBþ strains
were more prevalent than tcdAþtcdBþ strains, which is in
agreement with the findings of the previous studies.30 The
primary limitation of this study was the small number of
positive TXCD cases, which makes the statistical findings
less conclusive. In addition, this retrospective study was
performed without first isolating the C. difficile strains.acterization of enterotoxigenic Bacteroides fragilis and toxigenic
icrobiology, Immunology and Infection (2015), http://dx.doi.org/
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Taiwan tcdAtcdBþstrains predominate in patients with
confirmed C. difficile infections, which correlated with our
own study.
In conclusion, this ED-based epidemiological study shows
the prevalence rates and seasonal distribution of NTBF and
ETBF infections and the toxin genotypes of TXCD isolates in
Taipei during 2006e2009. This study analyzed the risk fac-
tors and clinical presentations of these anaerobic in-
fections. Putting this result with other results from related
studies together, we propose that ETBF and TXCD have
strong association with acute gastroenteritis.7,31e34 This
study demonstrates that ED staff must also pay attention to
anaerobic bacterial infections.
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